‌

Tahoe Therapeutics

Tahoe Therapeutics is building AI-powered models of the human cell to design better drugs for more patients. Its technology platform generates large-scale, perturbative single-cell datasets that enable a new generation of biological foundation models.

Overview Structured Data Issues Contributors

Is a

Company attributes

Industry

Artificial Intelligence (AI)

Location

South San Francisco, California

B2X

CEO

Founder

Number of Employees (Ranges)

11 – 50

Email Address

nima@tahoebio.ai

Full Address

681 Gateway Blvd. South San Francisco, CA, 94080

Investors

Databricks Ventures

Mubadala Capital

Civilization Ventures

Conviction Capital

Amplify Partners

General Catalyst

Total Funding Amount (USD)

30,000,000

Latest Funding Round Date

August 11, 2025

Latest Funding Type

Other attributes

Latest Funding Round Amount (USD)

30,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Tahoe Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.